MDS and AML @Point of Care™

@Point of Care™ With Watson is a clinical decision-making mobile platform. Myelodysplastic Syndromes and Acute Myeloid Leukemia @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care.

With Watson, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Watson, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care.

Myelodysplastic Syndromes and Acute Myeloid Leukemia @Point of Care™ is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care

Features:
• Continually updated Myelodysplastic Syndromes and Acute Myeloid Leukemia content
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients